West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$355.64 USD
+1.53 (0.43%)
Updated May 17, 2024 04:00 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
West Pharmaceutical Services, Inc. [WST]
Reports for Purchase
Showing records 101 - 108 ( 108 total )
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Hydraulic Presses for Biotechnology Success; 4Q and FY21 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Bioproduction: ''Guten Morgan Europe'' - Positive 2021 Industry Guides from Lonza and Sartorius
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Modeling COVID-19: Vaccine and Diagnostic Demand Outlook with Herd Immunity in 2021
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating at Overweight - Best Franchise in Healthcare? We Think So
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: West Pharmaceutical Services, Inc.
Industry: Medical - Dental Supplies
Initiating Coverage on Life Science Technology, Bioproduction, - Diagnostics
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department